The OrganaBio Blog

The Supply Brain

Addressing supply chain challenges in cell and gene therapy

OrganaBio Overview – Transforming a World of Research into a World of Cellular Therapies

In this presentation, OrganaBio’s CEO, Justin Irizarry, gives an overview of OrganaBio’s capabilities and how they can be leveraged to support the development and commercialization of cutting-edge cell and gene therapies. This talk was originally given at the 2021 Cell and Gene Meeting on the Mediterranean global conference. The conference brought together over 500 members of the cell and gene therapy community in an effort to stimulate collaborations and partnerships that accelerate the development of life-saving or life-altering therapies for patients in need.

Justin Irizarry

Justin Irizarry brings more than 17 years of entrepreneurial experience and executive-level leadership of business operations, finance, corporate development, and M&A. Previously, Justin co-founded OrthoNOW, the nation’s only network of immediate orthopedic care facilities. He led OrthoNOW through its various stages of growth and development, and his success has been featured in numerous publications, such as Entrepreneur Magazine, CFO Magazine, the South Florida Business Journal, the Miami Herald, the Orlando Sentinel, MedCity News, and Becker’s Hospital Review and the Pivotal Leader podcast.